NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced that it has updated the U.S. product labeling for CHANTIX® (varenicline), a prescription aid to smoking cessation treatment, to communicate important ...

The FDA has released the following: Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...

The recall is over the presence of nitrosamine being above the established Acceptable Daily Intake level by Pfizer. According to the company announcement, long-term ingestion of nitrosamine may be ...

The FDA has released the following: Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...

Pfizer has expanded a voluntary recall of its anti-smoking treatment Chantix, covering all lots of the drug's 0.5 and 1 milligram tablets. The affected products were distributed nationwide to ...

Tobacco is associated with immediate and long-term adverse clinical outcomes, including morbidity and mortality. Although Pfizer’s Chantix (varenicline tartrate) showed prominent efficacy for dry eye ...

Federal health officials said Monday that Pfizer's anti-smoking drug Chantix did not increase psychiatric problems like depression and suicidal thoughts in two studies, though the findings are not ...

For the third time this summer, Pfizer issued a recall of popular anti-smoking medication Chantix that might have too much of the carcinogen N-nitroso-varenicline. That’s too much for Pfizer, not the ...

When the smoking cessation medication, Chantix, was trending on Twitter Monday, it quickly became apparent that it wasn’t just because the manufacturer had recalled it. Yes, the recall of the drug ...